Neural effects of agomelatine on reward and aversion processing.

  • Research type

    Research Study

  • Full title

    The effects of agomelatine on neural responses to reward and aversion in healthy volunteers.

  • IRAS ID

    174605

  • Contact name

    Ciara McCabe

  • Contact email

    c.mccabe@reading.ac.uk

  • Sponsor organisation

    University of Reading

  • Duration of Study in the UK

    2 years, 0 months, 1 days

  • Research summary

    Anhedonia is the inability to experience pleasure from normally rewarding stimuli and is a core symptom of major depressive disorder (MDD). Research has demonstrated that people with MDD have abnormal brain responses to rewards and aversion in comparison to healthy controls. Using a paradigm involving a direct reward such as the taste of chocolate, we have shown that it is possible to delineate different neural systems supporting the representation of reward and pleasure in humans using functional neuroimaging (Rolls and McCabe 2007).

    Using this paradigm, we have extended this work to investigate the effects of psychopharmacological treatments on reward and aversion processing in healthy volunteers. For example, McCabe et al., (2010) found that the selective serotonin reuptake inhibitor (SSRI), citalopram, reduced brain responses to both rewards and aversion, in healthy volunteers. This has important implications regarding how antidepressant treatments interact with the reward centre of the brain and how they may affect anhedonia. More recently, we examined the effects of a dopamine-noradrenaline reuptake inhibitor, bupropion, in healthy volunteers at the University of Reading. This was achieved using an adapted version of the reward paradigm, which better separates wanting and liking aspects of reward and aversion processing.

    Using our newly advanced reward paradigm, this study aims is to investigate the effects of agomelatine on the neural responses to reward and aversion in healthy, never depressed, volunteers.

  • REC name

    South Central - Berkshire B Research Ethics Committee

  • REC reference

    15/SC/0229

  • Date of REC Opinion

    22 May 2015

  • REC opinion

    Further Information Favourable Opinion